Cargando…
Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden
BACKGROUND: Early treatment with disease modifying therapies (DMTs) for multiple sclerosis (MS) has been associated with lower disability progression; the aim was to explore its association with cost of illness (COI) in MS. METHODS: All people with relapsing-remitting MS in the Swedish MS register,...
Autores principales: | Karampampa, Korinna, Gyllensten, Hanna, Murley, Chantelle, Alexanderson, Kristina, Kavaliunas, Andrius, Olsson, Tomas, Manouchehrinia, Ali, Hillert, Jan, Friberg, Emilie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044795/ https://www.ncbi.nlm.nih.gov/pubmed/35496759 http://dx.doi.org/10.1177/20552173221092411 |
Ejemplares similares
-
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab
por: Karampampa, Korinna, et al.
Publicado: (2023) -
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden
por: Karampampa, Korinna, et al.
Publicado: (2019) -
Types of working-life sequences among people recently diagnosed with multiple sclerosis in Sweden: a nationwide register-based cohort study
por: Murley, Chantelle, et al.
Publicado: (2020) -
Costs of illness progression for different multiple sclerosis
phenotypes: a population-based study in Sweden
por: Gyllensten, Hanna, et al.
Publicado: (2019) -
Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden
por: Bütepage, Greta, et al.
Publicado: (2020)